XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2021 1,275 33,461        
Balance at Dec. 31, 2021 $ 1 $ 33 $ 205,305 $ (321,227) $ (4,350) $ (120,238)
Issuance of common stock (in shares) 0 341        
Issuance of common stock $ 0 $ 1 3,348 0 0 3,349
Stock options exercised (in shares) 0 263        
Stock options exercised $ 0 $ 0 196 0 0 196
Stock-based compensation $ 0 $ 0 2,040 0 0 2,040
Issuance and exercise of warrants (in shares) 0 113        
Issuance and exercise of warrants $ 0 $ 0 4,550 0 0 4,550
Foreign currency translation gain 0 0 0 0 (194) (194)
Net income (loss) $ 0 0 0 (18,294) 0 (18,294)
Series B conversion to common stock (in shares) (5)          
Series B conversion to common stock $ 0 $ 0 0 0 0 0
Series B conversion to common stock (in shares) 5          
Conversion of Stock, Shares Issued (in shares)   1        
Balance (in shares) at Mar. 31, 2022 1,270 34,179        
Balance at Mar. 31, 2022 $ 1 $ 34 215,439 (339,521) (4,544) (128,591)
Stock-based compensation $ 0 $ 0 2,040 0 0 2,040
Balance (in shares) at Dec. 31, 2021 1,275 33,461        
Balance at Dec. 31, 2021 $ 1 $ 33 205,305 (321,227) (4,350) (120,238)
Foreign currency translation gain           (884)
Net income (loss)           (85,348)
Balance (in shares) at Sep. 30, 2022 1,270 35,043        
Balance at Sep. 30, 2022 $ 1 $ 35 226,883 (406,575) (5,234) (184,890)
Balance (in shares) at Mar. 31, 2022 1,270 34,179        
Balance at Mar. 31, 2022 $ 1 $ 34 215,439 (339,521) (4,544) (128,591)
Issuance of common stock (in shares) 0 400        
Issuance of common stock $ 0 $ 1 5,123 0 0 5,124
Stock options exercised (in shares) 0 3        
Stock options exercised $ 0 $ 0 4 0 0 4
Stock-based compensation 0 0 1,349 0 0 1,349
Foreign currency translation gain 0 0 0 0 (390) (390)
Net income (loss) $ 0 $ 0 0 (209) 0 (209)
Balance (in shares) at Jun. 30, 2022 1,270 34,582        
Balance at Jun. 30, 2022 $ 1 $ 35 221,915 (339,730) (4,934) (122,713)
Stock-based compensation $ 0 $ 0 1,349 0 0 1,349
Issuance of common stock (in shares) 0 319        
Issuance of common stock $ 0 $ 0 2,872 0 0 2,872
Stock options exercised (in shares) 0 29        
Stock options exercised $ 0 $ 0 5 0 0 5
Stock-based compensation $ 0 $ 0 1,545 0 0 1,545
Issuance and exercise of warrants (in shares) 0 113        
Issuance and exercise of warrants $ 0 $ 0 546 0 0 546
Foreign currency translation gain 0 0 0 0 (300) (300)
Net income (loss) $ 0 $ 0 0 (66,845) 0 (66,845)
Balance (in shares) at Sep. 30, 2022 1,270 35,043        
Balance at Sep. 30, 2022 $ 1 $ 35 226,883 (406,575) (5,234) (184,890)
Stock-based compensation $ 0 $ 0 1,545 0 0 1,545
Balance (in shares) at Dec. 31, 2022 1,270 35,869        
Balance at Dec. 31, 2022 $ 1 $ 36 232,546 (428,985) (5,452) (201,854)
Issuance of common stock (in shares) 0 668        
Issuance of common stock $ 0 $ 1 2,616 0 0 2,617
Stock options exercised (in shares) 0 40        
Stock options exercised $ 0 $ 0 0 0 0 0
Stock-based compensation $ 0 $ 0 2,662 0 0 2,662
Issuance and exercise of warrants (in shares) 0 113        
Issuance and exercise of warrants $ 0 $ 0 448 0 0 448
Foreign currency translation gain 0 0 0 0 117 117
Net income (loss) $ 0 $ 0 0 (26,410) 0 (26,410)
Balance (in shares) at Mar. 31, 2023 1,270 36,690        
Balance at Mar. 31, 2023 $ 1 $ 37 238,272 (455,395) (5,335) (222,420)
Stock-based compensation $ 0 $ 0 2,662 0 0 2,662
Balance (in shares) at Dec. 31, 2022 1,270 35,869        
Balance at Dec. 31, 2022 $ 1 $ 36 232,546 (428,985) (5,452) (201,854)
Foreign currency translation gain           (127)
Net income (loss)           (20,978)
Balance (in shares) at Sep. 30, 2023 1,260 39,388        
Balance at Sep. 30, 2023 $ 1 $ 39 255,510 (449,963) (5,579) (199,992)
Balance (in shares) at Mar. 31, 2023 1,270 36,690        
Balance at Mar. 31, 2023 $ 1 $ 37 238,272 (455,395) (5,335) (222,420)
Issuance of common stock (in shares) 0 1,353        
Issuance of common stock $ 0 $ 1 6,298 0 0 6,299
Stock options exercised (in shares) 0 72        
Stock options exercised $ 0 $ 0 38 0 0 38
Stock-based compensation $ 0 $ 0 1,755 0 0 1,755
Issuance and exercise of warrants (in shares) 0 62        
Issuance and exercise of warrants $ 0 654 654
Foreign currency translation gain 0 0 0 0 16 16
Net income (loss) $ 0 $ 0 0 (25,279) 0 (25,279)
Series B conversion to common stock (in shares) (10) (1)        
Series B conversion to common stock $ 0 $ 0 0 0 0 0
Series B conversion to common stock (in shares) 10 1        
Balance (in shares) at Jun. 30, 2023 1,260 38,178        
Balance at Jun. 30, 2023 $ 1 $ 38 247,017 (480,674) (5,319) (238,937)
Stock-based compensation $ 0 $ 0 1,755 0 0 1,755
Issuance of common stock (in shares) 0 1,062        
Issuance of common stock $ 0 $ 1 5,850 0 0 5,851
Stock options exercised (in shares) 0 35        
Stock options exercised $ 0 $ 0 7 0 0 7
Stock-based compensation $ 0 $ 0 1,806 0 0 1,806
Issuance and exercise of warrants (in shares) 0 113        
Issuance and exercise of warrants $ 0 $ 0 830 0 0 830
Foreign currency translation gain 0 0 0 0 (260) (260)
Net income (loss) $ 0 $ 0 0 30,711 0 30,711
Balance (in shares) at Sep. 30, 2023 1,260 39,388        
Balance at Sep. 30, 2023 $ 1 $ 39 255,510 (449,963) (5,579) (199,992)
Stock-based compensation $ 0 $ 0 $ 1,806 $ 0 $ 0 $ 1,806